Merck & Co., Inc. MRK
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -87.11% | -80.66% | -48.75% | 6.64% | 56.68% |
| Total Depreciation and Amortization | 33.85% | 22.96% | 13.69% | 9.26% | 7.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6,544.50% | 354.88% | 189.43% | -85.26% | -94.43% |
| Change in Net Operating Assets | 47.21% | 58.14% | -22.02% | -90.24% | -290.41% |
| Cash from Operations | 9.60% | 7.73% | -14.31% | -23.27% | -6.56% |
| Capital Expenditure | 1.47% | -2.41% | 1.67% | -21.95% | -17.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,264,550.00% | -636.87% | -462.32% | -145.35% | 99.95% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,600.00% | 428.42% | 120.03% | 253.53% | -97.34% |
| Cash from Investing | -611.14% | -261.73% | -186.35% | -77.67% | 36.12% |
| Total Debt Issued | 232.29% | 2,577,400.00% | 313.39% | 283.91% | 65.66% |
| Total Debt Repaid | -135.10% | -135.21% | 62.39% | -94.03% | -303.18% |
| Issuance of Common Stock | 766.67% | 443.75% | 111.01% | -48.02% | -66.67% |
| Repurchase of Common Stock | 18.17% | -22.20% | -104.17% | -289.28% | -257.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.17% | -3.32% | -3.66% | -4.29% | -4.75% |
| Other Financing Activities | 32.47% | 24.29% | 75.14% | 81.72% | 30.63% |
| Cash from Financing | 111.36% | 141.84% | 108.54% | 72.67% | -54.47% |
| Foreign Exchange rate Adjustments | -145.66% | -105.03% | 38,700.00% | 292.15% | -33.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -340.99% | 64.18% | -208.92% | -78.59% | -40.65% |